Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World
Medicines specializes in acute care hospital products and also acquires, develops and commercializes pharmaceutical products in late stages of their development.